Skip to content
Finance Investment, General News

Proposed new powers to combat money laundering and terrorist financing to be reviewed

Parliament of Australia 2 mins read

The Parliamentary Joint Committee on Intelligence and Security (PJCIS) has commenced a review of the Anti-Money Laundering and Counter-Terrorism Financing Amendment Bill 2026.

The Bill, which was introduced into the Parliament on 12 March 2026, would enable the Chief Executive Officer of the Australian Transaction Reports and Analysis Centre (AUSTRAC) to restrict or prohibit reporting entities from using high-risk mechanisms to provide designated services; amend the meaning of financing of terrorism to reference new offences for financing a state sponsor of terrorism; and make technical amendments..

Chair of the PJCIS, Senator Raff Ciccone, said:

“Transnational serious and organised crime networks continue to evolve, finding new ways to exploit communities and economic systems for illegal gain and to conceal the proceeds of crime. As Governments strengthen protections across parts of the legitimate economy, criminals are increasingly turning to emerging technologies and changes in financial sector infrastructure to bypass safeguards.

This inquiry seeks to ensure the Bill is well‑suited to today’s rapidly changing financial crime landscape. This is an important review given the ongoing risks posed by money laundering and serious crime to both Australia’s financial system and the broader community, and the importance of maintaining an anti‑money laundering and counter‑terrorism financing (AML/CTF) framework that can respond effectively to emerging threats, now and into the future.”

The Committee invites written submissions to be provided by Friday, 8 May 2026.

Further details on the review are available on the Committee’s website: aph.gov.au/pjcis

Media enquiries

Office of Senator Raff Ciccone, Chair of the PJCIS
Contact: Giulio Di Giorgio, 0422 622 760
[email protected]

Background information

Committee Secretariat, Parliamentary Joint Committee on Intelligence and Security
02 6277 2360
[email protected]

For more information about this Committee, you can visit its website. On the site, you can make a submission to an inquiry, read other submissions, and get details for upcoming public hearings. You can also track the Committee and receive email updates by clicking on the blue ‘Track Committee’ button in the bottom right hand corner of the page.

More from this category

  • Finance Investment
  • 13/06/2026
  • 12:47
Defiance ETFs

Defiance ETFs Announces Temporary Trading Halt of the Defiance Daily 2X Space ETF (SPCL) on Cboe BZX Exchange, Inc.

MIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced that trading in shares of the Defiance Daily 2X Space ETF (Cboe BZX: SPCL) was temporarily halted by Cboe BZX Exchange, Inc. (the “Exchange”).Trading was temporarily halted at 10:45 A.M. EDT today.SPCL’s trading halt was the result of the Exchange exercising its broad discretionary authority to halt trading in a listed ETF, as authorized by Exchange rules. According to the Exchange, it currently anticipates lifting the temporary halt of trading in SPCL shares and resuming trading no earlier than Monday, June…

  • Finance Investment
  • 13/06/2026
  • 00:17
Defiance ETFs

SPCL Becomes the First and Only U.S. ETF With 2X SpaceX Exposure on IPO Day

MIAMI, June 12, 2026 (GLOBE NEWSWIRE) -- With SpaceX (NASDAQ: SPCX) expected to begin trading on the Nasdaq today, Defiance ETFs confirmed that the Defiance Daily 2X Space ETF (Cboe: SPCL) will seek 2X daily leveraged exposure to SpaceX Class A common stock within its portfolio, making it the first and only U.S. ETF to have 2X exposure to SpaceX on IPO day. The fund’s SpaceX exposure was established at the $135 IPO price.SpaceX priced its initial public offering at $135 per share and begins trading today under the ticker SPCX. At that price, the company is valued at approximately $1.77…

  • General News
  • 12/06/2026
  • 15:17
European Academy of Allergy and Clinical Immunology

EAACI Calls for a “Vision Zero” Future Free from Allergy and Asthma Burden

Leading allergy experts to convene in Istanbul to explore how science, prevention and policy can reduce the global impact of allergic diseasesZURICH, June 12, 2026 (GLOBE NEWSWIRE) -- As allergic diseases continue to affect hundreds of millions of people worldwide and place growing pressure on healthcare systems, the European Academy of Allergy and Clinical Immunology (EAACI) is calling for a new ambition in global health: Vision Zero, a future free from allergy and asthma burden.This vision will serve as the central theme of the EAACI Annual Congress 2026, taking place in Istanbul, Türkiye, from 12 to 15 June 2026, where…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.